Millennium Management’s Novartis NVS Stock Holding History

Millennium Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.41M	Buy	15,800 +8,100	+105%	+$1.24M	﹤0.01%	3689
2025 Q4	$1.06M	Buy	7,700 +1,000	+15%	+$131K	﹤0.01%	4441
2025 Q3	$859K	Hold	6,700	–	–	﹤0.01%	4731
2025 Q2	$811K	Sell	6,700 -28,300	-81%	-$3.19M	﹤0.01%	4567
2025 Q1	$3.9M	Buy	35,000 +18,500	+112%	+$1.97M	﹤0.01%	3109
2024 Q4	$1.61M	Sell	16,500 -11,900	-42%	-$1.27M	﹤0.01%	3809
2024 Q3	$3.27M	Sell	28,400 -26,400	-48%	-$3M	﹤0.01%	3224
2024 Q2	$5.83M	Buy	54,800 +8,100	+17%	+$813K	﹤0.01%	2583
2024 Q1	$4.52M	Buy	46,700 +37,000	+381%	+$3.79M	﹤0.01%	2963
2023 Q4	$979K	Sell	9,700 -78,300	-89%	-$7.56M	﹤0.01%	4182
2023 Q3	$8.96M	Buy	88,000 +23,900	+37%	+$2.43M	﹤0.01%	2146
2023 Q2	$6.47M	Buy	+64,100	New	+$6.41M	﹤0.01%	2419
2019 Q2	–	Sell	-223,200	Closed	-$19.2M	–	4347
2019 Q1	$19.2M	Buy	+223,200	New	+$17.9M	0.03%	822
2015 Q2	–	Sell	-3,236	Closed	-$286K	–	3673
2015 Q1	$286K	Buy	+3,236	New	+$287K	﹤0.01%	3069
2014 Q4	–	Sell	-6,026	Closed	-$508K	–	4179
2014 Q3	$508K	Buy	6,026 +1,450	+32%	+$117K	﹤0.01%	2739
2014 Q2	$371K	Buy	+4,576	New	+$360K	﹤0.01%	2760

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management's NVS Position: Q1 2026 in Review

Millennium Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 10,579 shares — an estimated $1.62M sold.

Millennium Management first reported a position in NVS in Q2 2013 and held it in 45 quarters. The position peaked at $120M in Q3 2018. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Millennium Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 10,579 Novartis shares in Q1 2026, an estimated $1.62M.
Millennium Management first reported a position in Novartis in Q2 2013 and held it in 45 quarters.
Millennium Management's Novartis position peaked at $120M in Q3 2018.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.